Medical Device Network
Abbott’s tissue valves obtain FDA approval for mitral valve replacement
The US Food and Drug Administration (FDA) has approved Abbott’s Epic Plus and Epic Plus Supra Stented Tissue Valves to boost treatment options for individuals with aortic or mitral valve disease.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact